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Abstract
Background: An increased incidence of imprint-associated disorders has been reported in babies born from assisted
reproductive technology (ART). However, previous studies supporting an association between ART and an altered DNA
methylation status of the conceived babies have been often conducted on a limited number of methylation sites and
without correction for critical potential confounders. Moreover, all the previous studies focused on the identification of
methylation changes shared among subjects while an evaluation of stochastic differences has never been conducted.
This study aims to evaluate the effect of ART and other common behavioral or environmental factors associated with
pregnancy on stochastic epigenetic variability using a multivariate approach.
Results: DNA methylation levels of cord blood from 23 in vitro and 41 naturally conceived children were
analyzed using the Infinium HumanMethylation450 BeadChips. After multiple testing correction, no statistically
significant difference emerged in the number of cord blood stochastic epigenetic variations or in the methylation levels
between in vitro- and in vivo-conceived babies. Conversely, four multiple factor analysis dimensions summarizing
common phenotypic, behavioral, or environmental factors (cord blood cell composition, pre or post conception
supplementation of folates, birth percentiles, gestational age, cesarean section, pre-gestational mother’s weight, parents’
BMI and obesity status, presence of adverse pregnancy outcomes, mother’s smoking status, and season of birth) were
significantly associated with stochastic epigenetic variability. The stochastic epigenetic variation analysis allowed the
identification of a rare imprinting defect in the locus GNAS in one of the babies belonging to the control population,
which would not have emerged using a classical case-control association analysis.
Conclusions: We confirmed the effect of several common behavioral or environmental factors on the epigenome of
newborns and described for the first time an epigenetic effect related to season of birth. Children born after ART did not
appear to have an increased risk of genome-wide changes in DNA methylation either at specific loci or randomly
scattered throughout the genome. The inability to identify differences between cases and controls suggests that the
number of stochastic epigenetic variations potentially induced by ART was not greater than that naturally produced in
response to maternal behavior or other common environmental factors.
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Background
Currently, there is still poor consensus on the possibility
that assisted reproduction technology (ART) could affect
the epigenome of in vitro-conceived babies [1–3].
Most of the studies addressing the DNA methylation sta-
tus of children conceived through in vitro fertilization (IVF)
with or without intracytoplasmic sperm injection (ICSI)
have specifically evaluated alterations in imprinted regions
[1, 2]. This on the basis of a suggested link between ART
and imprinting disorders. A recent meta-analysis including
the results of all the studies regardless of the type of the im-
printing disorder, showed a significant association between
imprinting diseases and ART (odds ratio = 3.67; 95% confi-
dence interval = 1.39–9.74) [2]. Beckwith-Wiedemann
syndrome, as an example, has an estimated worldwide fre-
quency of 1 in 13,700 naturally conceived babies and a
weighted relative risk of 5.2 in children conceived by ART
[2, 4]. Therefore, there is evidence to suggest an adverse ef-
fect of ART procedures, as well as of the underlying subfer-
tility, on imprinting status. The biological rationale behind
this idea is that because of the dynamic epigenetic repro-
gramming occurring during oocyte growth and preimplan-
tation development, environmental perturbations during
this time period may affect imprinting establishment and
maintenance. Proper allelic expression of imprinted genes
are known to play an important role in embryonic and
neonatal growth, placental function, and postnatal behavior
[1, 2, 4–7].
On the other hand, no evidence of generalized changes
in DNA methylation of the imprinted genes KvDMR/
KCNQIOTI, PEGI/MESR, IGF2, PEG3, and H19 in asso-
ciation with ART was found [2]. For instance, results of
a meta-analysis of four studies comparing percentage
methylation of IGF2 locus between ART and spontan-
eously conceived babies did not show any significant
difference [2]. Although imprinting syndromes are usu-
ally associated with profound methylation changes, even
the smaller scale changes that could be caused by ART
methodologies could potentially predispose to epigenetic
alterations at the key loci associated with the syndromes.
However, it is unlikely that these hypothetical changes in
the methylation status of newborns will be located in
genomic regions shared among subjects. Considering
that the reprogramming mechanism is driven by a rela-
tively small number of “players” [8], it is difficult to
figure out a mechanism where a potential interference
related to IVF techniques will result in a small localized
damage instead of a stochastic and more widespread ef-
fect. Indeed, the stochastic nature of these events has
been previously suggested based on data both in humans
and animal models [9, 10]. In addition to a potential
damage, a stochastic effect could also be related to a
rescue mechanism similar to the one observed in the
germinal cells of the progeny of Dnmt3L2/2 female
mice, where a hierarchy of factors involved in the estab-
lishment and maintenance of maternal germline im-
prints has been found, the loss of one possibly rescued
in a stochastic fashion by the activity of the others [11].
Given the supposed small and stochastic effects associ-
ated with ART, the analysis of mean methylation levels
may not be ideal in exploring differences between
in vivo- and in vitro-conceived children. This analysis
may be useful in identifying epigenetic alterations shared
by a group of subjects and potentially associated with
their phenotype but would not reflect differences in indi-
vidual variation or other features of the methylation
spectrum. Rare stochastic epigenetic variations that are
not shared among subjects fail to be identified by a clas-
sic Epigenome Wide Association Study (EWAS) based
on mean methylation values comparison [12]. To over-
come this problem, we have conducted an analysis of
stochasticity based on the previously introduced concept
of stochastic epigenetic variations (SEVs) [12]. SEV is
defined as a single CpG with a methylation level de-
tected as an outlier when compared to the methylation
level found for the same CpG in a control population.
This allows to obtain both a measure of stochasticity at
a whole-genome level (total number of SEVs) and a
topographic information on genomic regions with an
enriched number of SEVs. A previous application of this
method permitted to obtain an estimation of the number
of epigenetic alterations produced by aging, revealing an
exponential association between age and number of
SEVs [12]. Only four studies have previously evaluated
DNA methylation at a genome-wide level in cord blood
of human offspring from ART procedures, and this was
done based on the comparison of the mean methylation
levels [10, 13–15]. Importantly, correction for pheno-
typic parental or fetal traits was limited to none or very
few confounders although parental BMI, mode of deliv-
ery, birth weight, smoke, and intrauterine growth restric-
tion have been previously linked to changes in
methylation levels of several genes [16–19].
In this report, we present different analytical
approaches in evaluating global DNA methylation of
umbilical cord blood from in vitro and naturally con-
ceived newborns mostly with the aim to measure ran-
dom epigenetic variations and the impact of potential
confounders on their number.
Results
Dimensionality reduction of all phenotypic traits using
multiple factor analysis
Differences at phenotypic level between naturally con-
ceived (n = 41) and in vitro-conceived babies (n = 23)
were evaluated. The phenotypic traits considered were
birth weight, birthweight centiles, mother’ s age, parity
status, gestational age, cesarean section, sex of the baby,
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presence of adverse pregnancy outcomes (diabetes, pre-
eclampsia and placenta praevia), pre-gestational mother
weight, parents’ BMI and obesity, gestational weight in-
crease, maternal smoking status, pre-post conception
folate supplementation, blood cell composition [CD8 T
Cells (CD8T), CD4 T Cells (CD4T), natural killer (NK)
cells, B cells, monocytes, granulocytes], and season of
birth. The correlogram in Additional file 1: Figure S1
shows all the phenotypes analyzed and the presence of a
consistent degree of correlation among traits. The num-
ber of dimensions to use in the analysis was reduced
using the multiple factor analysis of mixed data. Consid-
ering the first two obtained dimensions (Dims), the over-
lap of cases and controls shown in Fig. 1a suggested a
phenotypic similarity between the two groups. Taken to-
gether, the first 10 dimensions collected 72% of the total
variability among the subjects analyzed. Correlations be-
tween dimensions and phenotypic traits were evaluated
and are shown in Fig. 1b. The logistic regression analysis
indicated that the Dim 1 and Dim 3 were significantly
associated with case-control status (p = 0.03 and p =
0.01, respectively) and were subsequently used as covari-
ates in the case-control differential methylation analysis.
Phenotypic traits that were mainly captured by Dim1
and Dim 3 were highlighted by elevated correlation
levels (Fig. 1b).
Visual inspection of DNA methylation level using
principal component analysis (PCA)
The genome-wide DNA methylation analysis of cord blood
was performed using the Infinium HumanMethylation450
BeadChip. Dimensional reduction was used to visually
inspect the dataset for strong signals in the methylation
values. The PCA was performed considering methylation
signals from single CpG sites and also considering four sets
of genomic regions: genes, promoters, CpG islands, and
tiling (not overlapping regions of 5 kb length). Results
reported in Fig. 2 show that there was no strong difference
in the methylation level between naturally conceived and
in vitro-conceived babies considering both sites and gen-
omic regions.
Differential methylation analysis
Differential methylation analysis was computed both for
site (single CpG) and region level. Dimensions obtained
from the multifactorial analysis, which were significantly
Fig. 1 Dimension reduction of phenotypic, behavioral and environmental traits. Dimension reduction obtained by multiple factor analysis of mixed data is
used to resume the complexity of all phenotypic, behavioral, and environmental traits. The scatter plot in (a) visualizes the samples into a two-dimensional
space using the first two dimensions. b shows a correlogram indicating correlation levels between dimensions and all the phenotypes used in the multiple
factor analysis. The highest correlation indicates that those traits are captured by that specific dimension. Dimensions highlighted in red were significantly
associated with case-control status while dimensions highlighted in black were significantly associated with the number of SEVs
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associated with the case-control status, and the chip batch
were used as covariates to adjust the differential methyla-
tion analysis. Moreover, surrogate variables analysis (SVA)
was applied in order to correct for potential unmeasured
or unmodeled confounders. At site level, no statistical dif-
ferences in methylation between cases and controls with a
genome-wide approach (p < 10− 7) emerged. A list of the
top 50 ranked probes as differently methylated is reported
in Additional file 2: Table S1. Differential methylation ana-
lysis performed at regional level was conducted consider-
ing the CpG islands, promoters, genes, and tiling. After
multiple testing correction, no statistical differences in
region methylation levels emerged between cases and con-
trols. QQ plots showing the level of inflation factor for
adjusted and not adjusted analyses are reported in
Additional file 3: Figure S2.
Comparative analysis of differences in methylation status
with previous EWAS
The differential methylation analysis is based on the as-
sumption that differences in methylation status are shared
among subjects. We have thus evaluated the consensus
among previous EWAS reporting differentially methylated
genes in the cord blood between in vivo- and
in vitro-conceived babies. The results presented with the
Venn diagram in Additional file 4: Figure S3 showed a lack
of consistency among the studies, with only 6 out of 214
genes found to be differentially methylated in at least two
different studies (NAP1L5, L3MBTL, GNAS, PEG10,
PRCP, and RUNX3). Importantly, none of these genes
were differentially methylated between cases and controls
in the present study, despite considering both adjusted
and unadjusted p values in the regional analysis conducted
for genes and promoters. Considering all the 214 genes
reported in the literature, only RNF185 [10] was found in
our study to include one of the top 50 ranked probes
reported in Additional file 2: Table S1. However, no en-
richment of differentially methylated probes was observed
for the gene RNF185 in our population, with only a single
probe out of eight associated with the gene resulting to be
nominally significant. Additionally, no differences were
detected in the regional analysis for genes and promoters
(unadjusted p values: 0.09 and 0.19 for gene and promoter,
respectively).
Fig. 2 Dimension reduction of methylation data. Dimension reduction is used to visually inspect the dataset for a strong signal in the methylation
values that is related to sample clinical or chip batch effects. Values of the first two principal components (PC) in scatter plots are shown considering
methylation levels of CpG sites (a) and methylation levels of regions such as genes (b), promoters (c), tiling (d), and CpG islands (e)
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Stochastic epigenetic variations analysis
For each subject, the total number of SEVs was calcu-
lated using three different reference populations as
described in the “Methods” section. The three differ-
ent estimations of the number of SEVs were then re-
ported using a logarithmic scale and indicated as
log(SEVs). The median number of log(SEVs) that was
calculated using the naturally conceived cord blood
reference was 5.9 (Q1 = 5.8; Q2 = 6.6) in cases
(in vitro-conceived babies) and 6.0 (Q1 = 5.9; Q2 =
6.3) in controls (in vivo-conceived babies) (Fig. 3a).
The median number of log(SEVs) calculated using the
naturally conceived cord blood GEO data reference
was 7.5 (Q1 = 7.3; Q2 = 7.7) in cases and 7.4 (Q1 =
7.2; Q2 = 7.6) in controls (Fig. 3b). The median num-
ber of log(SEVs) calculated using the general popula-
tion whole blood reference was 7.4 (Q1 = 7.2; Q2 =
7.6) in cases and 7.4 (Q1 = 7.2; Q2 = 7.6) in controls
(Fig. 3c). For all the estimations, no statistically sig-
nificant differences in log(SEVs) emerged between the
two groups analyzed. Moreover, the distribution of
log(SEVs) was very similar in cases and controls as
shown in the densitograms in Fig. 3d–f. A multivari-
ate logistic regression confirmed that no association
was present between log(SEVs) and case-control status
after adjustment for the set of covariates used in the
differential methylation analysis. Three different
regression models were performed according to the
three estimations of SEVs, and the results were finally
combined using the Fisher’s method. After multiple test-
ing correction, Fisher’s combined P value was equal to
0.38. An enrichment analysis was then conducted in order
to identify, in each subject, the number of genomic re-
gions that were enriched in SEVs. No differences between
ICSI and naturally conceived babies were detected in the
number of regions with enriched number of SEVs
(Additional file 5: Figure S4A–C). Also the distribution of
the number of regions enriched in SEVs number was simi-
lar between the two groups. (Additional file 5: Figure
S4D–F).
Stochastic epigenetic variations and imprinting defects
We have also checked for the presence of regions
enriched in SEVs in imprinted loci. The list of genes
and genomic coordinates under imprinting was se-
lected based on the paper by Court et al. [20]. The
analysis identified the presence of a single subject
with an enrichment of SEVs located at several differ-
entially methylated regions (DMRs) in the locus
GNAS (Additional file 6: Figure S5). In this subject
from the control group, the high number of reported
SEVs suggested a defect in the establishment or main-
tenance of methylation imprints. The epigenetic
defect was confirmed using the methylation-specific
multiplex ligation-dependent probe amplification
(MS-MLPA) (data not shown).
Fig. 3 SEVs and ART. For each subject, the total number of SEVs was calculated using three different reference populations. Differences between
cases and controls in the number and distribution of SEVs are shown. In panels a and d, SEVs were computed using naturally conceived cord
blood population as reference. In panels b and e, SEVs were computed using naturally conceived cord blood population obtained from GEO
database as reference. In panels c and f, SEVs were computed using general population whole blood as reference. Number of SEVs is reported in
logarithmic scale. Outer limits of the box represent the interquartile range, while the outer limits of the whiskers represent values equal to
Q1 – (3 × IQR) and Q3 + (3 × IQR). The central line in each box represents the median number of SEVs
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Stochastic epigenetic variations association analysis with
phenotypic, behavioral, and environmental traits
A multivariate regression analysis was performed in
order to identify phenotypic traits potentially associated
with SEVs. Three different regression models were
performed according to the three estimations of SEVs
and the results were finally combined using Fisher’s
method. Each multivariate regression model was created
considering the logarithmic number of SEVs as
dependent variable and the first 10 dimensions obtained
from the phenotypic multiple factor analysis as inde-
pendent variables. Results were adjusted considering the
chip batch effect. The multivariate regression showed
that the Dim 1, Dim 4, Dim 5, and Dim 9 were strongly
associated with the number of SEVs. After multiple test-
ing correction, Fisher’s combined p values were p = 4.0 ×
10− 4, p = 4.0 × 10− 4, p = 1.3 × 10− 3, and p = 5.0 × 10− 4,
respectively. The phenotypic traits captured by those
dimensions are shown in the correlogram in Fig. 1b.
Birthweight centiles, gestational age, cesarean section,
presence of adverse pregnancy outcomes, pre-gestational
mother’s weight, parents’ BMI and obesity, and cord
blood cells composition (CD8T, CD4T, and B Cells)
were significantly correlated to Dim 1 (p < 0.01, ρ > | 0.5
|). Birthweight centiles, mother’s smoking status were
significantly correlated to Dim 4 (p < 0.01, ρ > | 0.5 |),
cord blood cells composition (NK cells) and season of
birth were significantly correlated to Dim 5 (p < 0.01,
ρ > | 0.5 |) while Dim 9 captured mainly cesarean sec-
tion and pre- or post-conception folates supplementa-
tion (p < 0.01, ρ > | 0.4 |). The four most significant
traits observed to be correlated with SEVs (pre or
post conception folates supplementation, cesarean sec-
tion, mother’s obesity status and season of birth) are
shown in Additional file 7: Figure S6. The number of
SEVs reported has been obtained using the naturally
conceived cord blood reference.
Discussion
We report the most comprehensive multifactorial ana-
lysis of cord blood DNA methylation of in vitro con-
ceived babies and the first analysis of the stochastic
variations potentially induced by ART techniques.
Although the use of ART has allowed millions of other-
wise infertile couples to conceive children, some concern
still remains about the safety of these procedures [2, 21].
An increase in imprinting disorders has been found in
children conceived through IVF and ICSI, but no evi-
dence of generalized changes in DNA methylation could
be appreciated [2]. Our results are in line with this
observation based on two different approaches: (i) a con-
ventional epigenome-wide association analysis. At both
site and region levels, no differences in methylation
status between naturally and in vitro conceived emerged
as statistically significant; (ii) a previously published
method aimed at investigating the number and the
localization of stochastic epigenetic variations [12, 22].
Although several studies have tried to investigate the
methylation status of ART-conceived babies, only four
EWAS were previously conducted on this topic.
Melamed et al. have evaluated 27,578 CpG sites in cord
blood from 10 children conceived in vitro and 8 con-
ceived in vivo [10]. Castillo-Fernandez et al. investigated
the links between IVF and DNA methylation patterns in
47 IVF and 60 non-IVF newborn twins (from 54 twin
pairs) in whole cord blood cells and cord blood mono-
nuclear cells using genome-wide methylated DNA im-
munoprecipitation coupled with deep sequencing [13].
Estill et al. reported the methylation profiles of neonatal
blood spots of 137 babies conceived naturally or with
four different ART techniques [14]. Finally, El Hajj N
et al. evaluated the methylome of 48 babies conceived
with ICSI [15]. Both Estill et al. and El Hajj N et al. used
the Infinium HumanMethylation450 BeadChips to
analyze the methylation levels [14, 15]. Notwithstanding
the lack of an adequate correction for crucial confound-
ing factors, only a small number of CpG sites was differ-
entially methylated at a genome-wide level and the
magnitude of differences identified was also extremely
small [10, 13–15]. Furthermore, when considering all
the studies together, we observed a substantial inconsis-
tence among their results. Only six genes have been con-
firmed in at least two studies (NAP1L5, L3MBTL,
GNAS, PEG10, PRCP, and RUNX3).
Interestingly, a review of literature concerning those
genes revealed that they are already known to be epige-
netically associated with other pregnancy conditions.
NAP1L5, for example, has been previously identified to
be differently methylated in cord blood samples charac-
terized by intrauterine exposure to gestational diabetes
mellitus [23]. L3MBTL has been reported to be differ-
ently methylated in cord blood of babies exposed to
smoking during pregnancy [24] and is epigenetically
associated with gestational age [25]. Increased methyla-
tion at differentially methylated regions of GNAS has
been described in infants born in conditions of gesta-
tional diabetes [26]. An increase in DNA methylation at
the SGCE/PEG10 DMR has been previously positively
associated with paternal BMI [27], maternal stress [28],
and also with maternal prenatal physical activity [29].
Methylation of PRCP gene in newborns [30] as well as
RUNX3 [24] was found to be significantly associated
with maternal smoking status. Hypermethylation of
RUNX3 CpG sites has been also associated with
decreased gestational age [24]. Taken together, this evi-
dence hints at the presence of confounding factors in
previously reported results on epigenetics of ART. This
observation seems to be supported by analysis of the
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QQ-plot obtained from unadjusted analysis presented
herein. The elevated genomic inflation factor (lambda =
1.7; Additional file 3: Figure S2) observed in unadjusted
analysis sheds light on the excess of false positive rate
potentially produced under inadequate correction. The
influence of confounding factors on epigenome of cord
blood has been extensively described. Soubry et al., for
example, demonstrated a significant association between
parental BMI and DNA methylation of imprinted genes
[29]. This finding should be considered as relevant since
a significant effect of ART has been reported to affect
imprinted loci [15].
An increased variability of DNA methylation in IVF
conceived babies was previously underlined, hinting at
the presence of epigenetic changes not shared among
subjects [10] and thus supporting the idea that the effect
of ART might be more likely to be stochastic rather than
confined to some genetic regions. Our novel analytical
approach addressing the number of stochastic epigenetic
variations [12, 22] showed no differences in cord blood
from in vitro and in vivo conceived babies.
The analysis of SEVs proposed in the present study
proved to be a powerful approach to study the epigenetic
variability and allowed to study the impact of several con-
ditions on the newborn epigenome. Interestingly, four
dimensions obtained from the dimensional reduction of
phenotypic traits were significantly associated with the
number of SEVs. Cord blood cell composition, pre or post
conception supplementation of folates, birth percentiles,
gestational age, cesarean section, pre-gestational mother’s
weight, parental BMI and obesity, presence of adverse
pregnancy outcomes, mother’s smoking status, and season
of birth were the traits mainly captured by these dimen-
sions. Some of these factors such as parental BMI, gesta-
tional age, birth weight, and smoking are already known
for playing a role on the newborn epigenome [20, 25, 27–
29, 31]. Of note, we observed and reported for the first
time the existence of an epigenetic signature associated
with season of birth. The number of stochastic epigenetic
variations was lower in subjects born in autumn. This
observation should be considered important for at least
two reasons: (i) seasonality of birth has already been
reported to be associated with an increased incidence of
several pathological conditions such as type I diabetes [32,
33], cardiovascular disease [34], skin cancer [35], and
autoimmune diseases [36]. Moreover, seasonality of birth
has been also studied in the field of aging and is associated
with life expectancy [37–40]; (ii) the magnitude of the
effect of seasonality, a natural event, on epigenome of
newborns appeared to be greater compared to the one in-
duced by ART.
We have also evaluated the presence of SEVs in
imprinted loci failing to find significant differences be-
tween cases and controls. A single epigenetic alteration
in the locus GNAS was found in a control subject. It is
important to note that the new method applied in this
study allowed not only to evaluate the number of SEVs
located across the whole genome, but also succeeded in
the identification of a single epigenetic alteration subse-
quently confirmed using MS-MLPA and not shared
among subjects. A standard case-control analysis would
have failed to identify this particular defect. To our
knowledge, this is the first study addressing a
genome-wide analysis of imprinted loci taking into
account the probable random effect of ART and applying
a test that does not require the possible epigenetic vari-
ation to be present in more than one subject. In any
case, we realize that these phenomena do represent rare
events, and we probably need a greater sample size to
completely exclude a direct effect at the level of specific
imprinting genes.
The present work has clarified that the number of sto-
chastic epigenetic variations potentially induced by ART
technology was, at worst, comparable to that naturally
produced in response to maternal behavior or other
common environmental factors, thus debunking the idea
of a severe impact of ART in the epigenome of the new-
borns and implying a reconsideration of the epigenetic
safety of these techniques.
Another crucial aspect of the present work is the
analysis of all the potential confounders that could
affect the methylation status in the newborn cord
blood. It is totally unexpected that previous studies
on the same topic evaluating genome wide DNA
methylation [10, 13–15] failed to correct for factors
potentially affecting methylation status or considered
only a small number of them. Therefore, given the
complexity of the networks and of the phenotypic
traits involved in pregnancy establishment, the causal
relationship between the epigenetic status and ART
needs to be evaluated with caution and controlling
for potential confounders. The complexity of the
phenotypic traits represents also another important
issue; the correlation analysis performed among
phenotypic traits revealed the existence of several hid-
den associations among variables, and this needs to
be considered when adjusting for confounders in
order to avoid multicollinearity.
Another aspect that is often disregarded is the po-
tential role of ART techniques on placenta methyla-
tion status and the consequent effect on birth weight
and on the epigenome of newborns. Recent studies
conducted in animal models reported that ART has a
predominant or exclusive effect on the placenta
methylation status compared to that on the fetus [9,
41, 42]. An attractive hypothesis that comes from
these data is that the higher incidence of premature
birth and low birth weight observed in
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ART-conceived children may be related to abnormal
placental function resulting from genomic imprinting
errors at multiple genes. Recently, Ghosh et al. re-
ported evidence of placental methylation altered by
ART procedures at repeated sequences (LINE1 ele-
ments) and CCGG sites [43]. Similarly, Choux et al.
reported lower DNA methylation for two imprinted
loci (H19/IGF2 and KCNQ1OT1 DMRs) and two
transposon families (LINE-1Hs and ERVFRD-1) in the
placenta of babies conceived by ART [44]. Interest-
ingly, DNA methylation of the same imprinted genes
DMRs and transposable elements in cord blood was
not altered by ART procedures, thus confirming the
main effect at the placental level as seen in animal
experiments. A whole genome analysis of the methy-
lation status of placenta samples from babies con-
ceived by ART is needed in order to elucidate this
crucial aspect.
A number of limitations need to be considered when
interpreting our results. First, only DNA from cord
blood was analyzed. Since cord blood is not necessarily
representative of the epigenetic status of all tissues and
cells in the newborn, additional studies on other tissues
are mandatory to confirm these data. Second, the pheno-
typic data of the studied subjects did not include all the
possible variables related to pregnancy and labor
although a surrogate variables analysis was conducted to
compensate for this deficiency. Third, although the
number of subjects used for comparisons is of the same
order of magnitude of previously conducted EWAS, we
must underline that a larger sample size could better
estimate normal ranges of DNA methylation in each
locus. Confirming our results on a larger sample size
would allow to exclude the possibility that small methy-
lation differences have gone undetected. Fourth, these
findings represent the experience relative to the ICSI
procedure of a single IVF center and a single lab.
Although we selected only ICSI procedures in order to
analyze a homogeneous group of babies obtained using
the more invasive technique, we cannot exclude that
procedures done in different ways and with different
technologies could result in different data. Moreover, it
should be considered that when comparing naturally
conceived and in vitro-conceived babies, there is a con-
sistent number of inescapable differences between the
two groups such as parents’ infertility status that may
represent an important selection bias. Finally, although
the Infinium HumanMethylation450 BeadChips covers
99% of RefSeq genes, permitting a whole-genome ana-
lysis, the coverage of total CpG sites is low (around 2%).
This means that sequencing-based methods should be
adopted in the future in order to study other genomic
features (e.g., enhancers) that have only small coverage
in the present analysis.
Conclusions
The presented prospective study does not support that
children born after ART have an increased risk of
genome-wide changes in DNA methylation neither at
specific loci neither randomly scattered throughout the
genome. On the other hand, the study confirms that
there are several environmental and behavioral condi-
tions able to affect epigenetic variability in cord blood
and leads to the conclusion that they need to be consid-
ered as potential confounders in investigations of this
nature.
A reanalysis of previous data based on phenotypic
traits of the parents and the babies potentially associated
with epigenetic changes is warranted as well as a
meta-analysis including all the data from genome-wide
studies.
Methods
Study design and study population
This is a prospective study designed to avoid biases related
to the improper selection of complicated pregnancies in
one of the two groups. Women that underwent ICSI treat-
ment were enrolled in the study at 20 weeks’ gestation.
These women were stimulated with standard ovulation
induction drugs. Pregnant women who naturally con-
ceived were also enrolled at 20 weeks’ of gestation. The
in vivo group had no history of infertility, and the index
pregnancy was achieved without medications or treat-
ments. None of the pregnancy ended in abortion, and all
the patients were included in the study. Samples of cord
blood from both ART-conceived pregnancies (n = 23) and
naturally conceived pregnancies (n = 41) were obtained at
the time of delivery by the midwives of the San Raffaele
Hospital, Milano, Italy, by puncturing the umbilical vein
while the placenta was in utero [45]. Patients were
informed that cord blood would be used for research pur-
poses and gave written consent. Approval for this study
was granted by the local Human Institutional Investiga-
tion Committee (#PMAMET). Clinical information
obtained for each pregnancy included demographic and
obstetric factors, cause of infertility, details of the ART
procedure as well as pregnancy, delivery, and neonatal
outcomes. Multifetal gestations were excluded from both
groups.
Sample size was calculated based on the analysis of pa-
rameters observed in a previous study in which more
than 400 subjects were evaluated [12]. Mean and vari-
ance were estimated for all the CpG sites of the Infinium
HumanMethylation 450 BeadChip array. The number of
subjects to be enrolled has been calculated assuming an
effect size taking into account a difference in the per-
centage of methylation between groups of at least 10%,
by imposing a probability of type I error in the order of
10− 7 (level of significance that takes into account the
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need to correct for multiple testing) and a power of 95%.
A description of the study design is shown in
Additional file 8: Figure S7.
In vitro fertilization procedures
Controlled ovarian stimulation was performed according
to the clinical practice and as previously described [46–48].
Oocyte collection was performed 36 h after triggering of
ovulation. After 2–3 h incubation in Human Serum
Albumin (HSA)-supplemented Fertilization medium (Sage
In-Vitro Fertilization, Inc. Trumbull, CT, USA) under oil,
denudation of the cumulus oophorus was performed as
previously described [46, 49, 50]. Injected oocytes were
grouped-cultured in microdrops of equilibrated Serum
Substitute Supplement (SSS, Irvine, CA, USA)-supplemen-
ted Cleavage medium (Sage In-Vitro Fertilization, Inc.
Trumbull, CT, USA) under oil. Sixteen to 18 h after ICSI,
all oocytes were checked for fertilization as previously de-
scribed [46, 49, 50]. For a subgroup of patients (n = 7,
30.4%), embryos were cultured to blastocyst stage in SSS
(Irvine, CA, USA)-supplemented Blastocyst medium (Sage
In-Vitro Fertilization, Inc. Trumbull, CT, USA). All the
incubation steps were conducted using low (5%) oxygen
concentration incubators [49]. All the transfers were per-
formed in fresh cycles [48]. All the patients underwent
luteal phase support with progesterone 600 mg/d (Prome-
trium) administered vaginally and continued through week
12 of pregnancy.
DNA extraction and bisulphite treatment of the DNA
Genomic DNA was extracted from cord blood using the
Wizard genomic DNA purification kit (PRO-
MEGA, Madison WI, USA) as previously described [12].
Quality control and quantification of DNA were per-
formed before and after bisulphite conversion. DNA was
quantified with NanoDrop (NanoDrop Products Thermo
Scientific, Wilmington, DE, USA) and quality was
assessed by visualization of genomic DNA on 1% agarose
gel electrophoresis. Only DNA samples not fragmented
and with a concentration higher than 50 ng/μl were sub-
sequently processed.
DNA methylation assay
4 μl of bisulfite-converted DNA was used for hybridization
on Infinium HumanMethylation 450 BeadChip, following
the Illumina Infinium HD Methylation protocol. This con-
sists of a whole genome amplification step followed by
enzymatic end-point fragmentation, precipitation, and re-
suspension. The resuspended samples were hybridized on
HumanMethylation 450 BeadChips at 48 °C for 16 h.
Then, unhybridized and non-specifically hybridized DNA
were washed away followed by a single nucleotide exten-
sion using the hybridized bisulfite-treated DNA as a tem-
plate. The nucleotides incorporated were labeled with
biotin (ddCTP and ddGTP) and 2,4-dinitrophenol (DNP)
(ddATP and ddTTP). After the single base extension,
repeated rounds of staining were performed with a com-
bination of antibodies that differentiate DNP and biotin by
fixing them different fluorophores. Finally, the BeadChip
was washed and protected in order to scan it. The Illumina
HiScan SQ scanner is a two-color laser (532 nm/660 nm)
fluorescent scanner with a 0.375 μm spatial resolution cap-
able of exciting the fluorophores generated during the
staining step of the protocol. Image intensities were
extracted using GenomeStudio (2010.3). The methylation
score for each CpG site was represented as β values
according to the fluorescent intensity ratio between meth-
ylated and unmethylated probes. β values may range
between 0 (unmethylated) and 1 (completely methylated).
Data management, pre-processing, normalization, and
quality control
Illumina Methylation 450K raw data were analyzed
using the RnBeads analysis software package [51].
Sites with overlapping SNPs were firstly removed
from the analysis (n = 4713) as well as probes on sex
chromosomes (n = 11119). Possible removal of probes
and samples of highest impurity from the dataset was
evaluated using the Greedycut algorithm. We consid-
ered every β value to be unreliable when its corre-
sponding detection p value was not below the
threshold (T = 0.05). In order to avoid an erroneous
interpretation of stochastic epigenetic variations,
probes with coordinates overlapping rare genetic vari-
ants annotated in 1000 genomes and EXAC databases
were removed [52, 53]. After the quality control step,
none of the samples was excluded for quality reasons
while a total of 14208 probes were removed. The
background was subtracted using the methylumi
package (method “noob”) [51]. The signal intensity
values were normalized using the SWAN
normalization method, as implemented in the minfi
package. In addition to CpG sites, four sets of gen-
omic regions were covered in the analysis (tiling,
genes, promoters and CpG Islands).
Blood cell type counts
Proportions of CD8 T cells, CD4 T cells, NK cells, B cells,
monocytes, and granulocytes were estimated using the
“estimateCellCounts” function in the Bioconductor minfi
package [54] with the reference data for cord blood pro-
vided by Bakulski et al. [55].
Differential methylation analysis
Differential methylation analysis was conducted both at
site and region level according to the sample groups. p
values were computed using the limma method for the
site level analysis while a combined p value was
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calculated from all site p values for the region-based
[51]. Regions were defined according to RnBeads defini-
tions [51]:
– Genes and promoters: Ensembl [56] gene definitions
were downloaded using the biomaRt package. A
promoter was defined as the region spanning 1500
bases upstream and 500 bases downstream of the
transcription start site of the corresponding gene.
– GpG islands: the CpG island track was downloaded
from the dedicated FTP directory of the UCSC
Genome Browser [57].
– Tiling regions: not overlapping tiling regions with a
window size of 5 kb were defined over the whole
genome.
In order to avoid potentially confounding factors, a
multiple factor analysis (MFA) was performed based on
phenotypic data (birth weight, birthweight centiles,
mother’ s age, parity status, gestational age, cesarean
section, sex of the baby, presence of adverse pregnancy
outcomes, pre-gestational mother weight, parents’ BMI
and obesity status, gestational weight increase, smoking
status, pre-post conception folate supplementation,
CD8T, CD4T, NK cells, B cells, monocytes, granulocytes,
season of birth). Variables were entered in the analysis
as factorial or linear values. Chip batch and dimensions
that were significantly associated with the case-control
status were used as covariates in the differential methy-
lation analysis. Adjustment for surrogate variables was
conducted using the function directly provided in the
package RnBeads, which can detect batch effects and
other unwanted variation of unknown origin and anno-
tate them in such a way that they can be controlled for
as covariates [51].
Epigenetic variations detection
In order to identify stochastic epigenetic variations (SEVs),
we used a method previously described by our group [12,
22]. Briefly, after the pre-processing step, the distribution
and variability of methylation levels were studied in the
populations for all the probes of the array using box and
whiskers plots. At each CpG site, the methylation level of a
subject that was extremely different from the rest of the
population was counted as an epigenetic variation. Thus,
for each locus, epigenetic variations were identified as the
extreme outliers, with their methylation level that lied out-
side of Q1 − (3 × IQR) and Q3 + (3 × IQR). Finally, all the
observed epigenetic variations were annotated in a new
data matrix that allowed to calculate, for each subject, the
total amount of epigenetic variations and their genomic
position. The box and whiskers plot analysis was conducted
using boxplot function in the R car package and confirmed
using the outlier function in the R outliers package.
In addition to the previously described control popula-
tion composed by 41 natural conceived babies, two other
different reference populations have been used for this
analysis:
1) Methylation row data from 60 subjects were obtained
from the public functional genomics data repository
GEO.We have selected two different datasets
containing methylation data from cord blood samples
(GSE54399, GSE30870), and we have extracted only
methylation data from control subjects. This
population (naturally conceived cord blood GEO data
reference) represented our “external” control
population. GEO and in house raw data were pre-
processed following the same procedure.
2) Methylation row data from 350 healthy subjects
with an age spanning from 1 to 107 years were also
obtained from the Istituto Auxologico Italiano
Epigenetic Database. This population represented a
second reference population used for the estimation
of epigenetic variations (general population whole
blood reference).
A schematic description of the strategy used to obtain
different estimations of the number of SEVs by using the
various reference populations is shown is Additional file 9:
Figure S8.
Briefly:
– In the first step, the analysis described above was
applied on naturally conceived cord blood
population. Samples were analyzed together, and the
number of SEVs was calculated in each control
subject.
– In a second step, all the samples in the case group
were tested individually using the naturally
conceived cord blood reference and the number of
SEVs was calculated for each case subject.
– In the third step, the naturally conceived cord blood
GEO data reference was used to calculate the
number of SEVs both in cases and control subjects.
Also in this step, each subject was tested
individually.
– Finally, the general population whole blood reference
was used to calculate the number of SEVs both in
control and case subjects. Also in this step, each
subject was tested individually.
Using three different reference populations, three different
estimations of the number of SEVs were calculated for each
subject. A test for over-representation of these probes was
conducted, for each subject, using sliding windows and the
hypergeometric cumulative function, obtaining the number
of genomic regions that were enriched in SEVs [12].
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Validation of the SEVs analysis
In order to confirm the power of this analytical approach
to detect epigenetic variations, two separate tests were
performed on positive controls. Three samples were ana-
lyzed in duplicates, and epigenetic variations found in
each of them were compared. Results showed a mean
correlation of 0.99 (p < 0.01) among the experiments.
The duplicate samples underwent independent bisulfite
conversion reactions, and this suggests that epigenetic
variations are not significantly influenced by bisulfite
conversion errors. In the second validation step, 48
whole blood DNA samples obtained from subjects
affected by imprinting diseases (Beckwith-Wiedemann
syndrome, Angelman syndrome and Silver Russel syn-
drome) who underwent diagnostic assays at Istituto
Auxologico Italiano were analyzed. For these subjects, a
medical report indicating the genomic position of their
epigenetic alteration was already available. Briefly, after
the identification of the outlier probes, a test for
over-representation of these probes inside each gene was
performed using the hypergeometric cumulative func-
tion. The analysis identified genes with enriched number
of outliers probes (Bonferroni’s corrected p value < 0.05)
confirming the presence of the epigenetic alterations
previously reported in the medical report.
Statistical tests
The “Shapiro.test” function provided in the R package
“stats” was applied to test normality among variables.
The “Wilcox.test” function provided in the R package
“class” was used to test differences between cases and
controls groups for all non-parametric data. Consider-
ing the presence of categorical variables, dimensional
reduction was performed using the multiple factor
analysis of mixed data approach and the “FAMD”
function provided in the R package “FactoMineR.”
The univariate and multivariate linear regressions
were conducted using the “Generalised Linear Model”
function provided in the R “base” package. Bonferro-
ni’s correction was performed to correct for multiple
testing. Correlation analysis between Dims and envir-
onmental and behavioral conditions has been
performed using the hector function provided in the
package “polycor.”
Comparative analysis with previous EWAS
We conducted a systematic search of the literature
focusing on studies that used a genome-wide approach
(Illumina Infinium HumanMethylation27 BeadChip and
Illumina Infinium Human Methylation 450K BeadChip)
with the aim to compare cord blood methylation levels
between in vitro and in vivo conceived babies. The four
selected studies [10, 13–15] reported differentially meth-
ylated genes using different parameters for the selection.
Melamed et al. identifies genes that had at least two sig-
nificantly differentially methylated CpG sites and genes
with at least a CpG site showing a significant methyla-
tion difference ≥ 10% between ART and control groups
[10]. A total of 33 genes were found. Estill et al. consid-
ered as significant all those genes with a minimum abso-
lute average methylation change of 2.5% for the clusters
of CpGs that were associated with a given gene (at least
75% of the cluster intersecting a gene body or pro-
moter), with only the significant clusters that were
considered in the average count [14]. The study reported
a list of differentially methylated metastable epialleles,
imprinted genes, and genes related to differentially
methylated enhancers. A total of 87 genes as having
significantly different methylation status emerged when
comparing babies born with various ART techniques
and naturally conceived. Castillo-Fernandez et al. re-
ported a list of all the genes located near each differ-
entially methylated CpGs between the two groups
selected using a false discovery rate equal to 25%
[13]. A total of 66 genes were found to be associated
with the 46 reported differentially methylated regions.
Finally, El Hajj et al. reported a list of 34 genes with
a methylation difference of β > ±0.03 and an adjusted
p < 0.05 observed in promoters, imprinting control re-
gions and CpG islands [15].
Additional files
Additional file 1: Figure S1. Correlation analysis among phenotypic,
behavioral and environmental features considered in the study. Degree
and direction of correlations are highlighted by the color and dimension
of squares. (TIF 307 kb)
Additional file 2: Table S1. Top 50 ranked hypomethylated or
hypermethylated probes in babies born after ICSI. (XLS 41 kb)
Additional file 3: Figure S2. QQ plots obtained using (A) Dim1 and
Dim3 resulted from the multiple factor analysis of mixed data. (B)
Surrogate variable analysis (SVA), and Dim1 and Dim3 obtained from the
multiple factor analysis of mixed data as covariates in the differential
methylation analysis. The QQ plot obtained without data correction is
illustrated in C. The elevated genomic inflation factor of unadjusted data
suggests presence of potential confounders. (TIF 141 kb)
Additional file 4: Figure S3. Venn diagram illustrating the number of
genes found in literature to be differentially methylated in cord blood of
ART babies when compared to natural conceived babies and the
overlapping of results among previous EWAS [10, 13–15]. (TIF 234 kb)
Additional file 5: Figure S4. For each subject, the total number of
region enriched in SEVs was calculated using three different reference
populations. Differences between cases and controls in the number and
distribution of region enriched in SEVs are shown. In panels A and D,
SEVs were computed using naturally conceived cord blood population as
reference. In panels B and E, SEVs were computed using naturally conceived
cord blood population obtained from GEO database as reference. In panels
C and F, SEVs were computed using general population whole blood as
reference. Number of region enriched in SEVs is reported in logarithmic
scale. Outer limits of the box represent the interquartile range, while the
outer limits of the whiskers represent values equal to Q1 − (3 × IQR) and Q3
+ (3 × IQR). The central line in each box represents the median number of
SEVs. (TIF 181 kb)
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Additional file 6: Figure S5. Genomic regions under imprinting control
carrying an epigenetic alteration in a control subject. In panel A,
stochastic epigenetic variations (SEVs) detected in the cord blood of a
single subject from the control population are represented in red while
the differentially methylated regions (DMRs) reported by Court et al. [18]
are represented in blue. The high number of reported SEVs suggested a
defect in the establishment or maintenance of methylation imprints
confirmed using MS-MLPA. Panel B illustrates the magnification of one of
the DMRs. (TIF 1062 kb)
Additional file 7: Figure S6. Effect of folates supplementation, mother’s
obesity status, cesarean section, and season of birth on number of SEVs.
Number of SEVs is reported in logarithmic scale. Outer limits of the box
represent the interquartile range, while the outer limits of the whiskers
represent values equal to Q1 – (3 × IQR) and Q3 + (3 × IQR). The central
line in each box represents the median number of SEVs. (TIF 107 kb)
Additional file 8: Figure S7. Schematic representation of the study
design. (TIF 1116 kb)
Additional file 9: Figure S8. Schematic description of the strategy used
to estimate the number of SEVs. (TIF 982 kb)
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